The drugs and devices have been on the market for years, but FDA-ordered studies still aren't done
An analysis of FDA data found hundreds of postmarket studies running behind schedule, raising questions about the agency’s ability to ensure manufacturers follow through.
← Back to stories
National4 articles from 4 sources across the spectrum· Updated 7d ago
3 across the spectrum · tap a section to jump
How each side is putting it
Left
1 viewpointThe FDA requires follow-up studies for drugs and devices. Years later, many still aren’t done
The Drugs and Devices Have Been on the Market for Years. But FDA-Ordered Studies Still Aren’t Done.
Center
2 viewpointsThe drugs and devices have been on the market for years, but FDA-ordered studies still aren't done
FDA-ordered studies of many drugs and devices already on the market are not done
Right
0 viewpointsNo Right coverage yet.
A blind spot on this side of the story.